Startups Directory

Flexor Biomechanics is a startup with origin in the University of Seville and University Pablo de Olavide (Seville). As a result of the research developed by the research groups of these two Universities, a mechanical device and a software have been developed to measure the mechanical properties (stiffness and viscosity) of the lower limb. These measurements are non-invasive and involuntary. The mechanical device has a patent. These measurements are useful in medical assessments as well as in monitoring sport performance.

In-vivo and non-invasive mesurements of mechanical properties of muscle-tendon complexes.

The mechanical device and its software will help medical assessments and in monitoring sport performance.

200.000€

200.000€

Pinep Experience S.L. is a Knowledge-Based Enterprise (KBE) affiliated with the University of Málaga. We provide innovative Conscious Emotional Management (PINEP) solutions. Our project arises as a response to the increasing corporate need to identify, enhance, and build loyalty among talent, as well as to improve well-being in the work environment. Our vision holds that efficient emotional management is the cornerstone that guarantees competencies and talent are truly applied during times of pressure or difficulty.

Current talent assessment methods are predominantly based on subjective, retrospective questionnaires and static interviews. These tools fail to capture a candidate's actual physiological and emotional response to real-time stress. Consequently, organizations face a 'data blindness' that leads to: 1. High Turnover: Employees placed in high-pressure roles without the actual emotional resilience required. 2. Rising Costs: Millions lost annually due to burnout-related sick leave and productivity drops. 3. Subjectivity Bias: Hiring and promotion decisions based on social desirability rather than objective, biological evidence of stress management.

We are developing a tool to objectively measure Conscious Emotional Management using cortisol biomarkers. Our technology creates a scientific standard to evaluate how people handle high-pressure situations. By providing objective data on emotional coping, we help companies build healthier environments where wellbeing strategies are based on evidence, not just opinions. This is a key step to transform mental health into a measurable and manageable asset.

We are seeking €150000 to fund the integration of the Factor G platform. This investment will cover the digital development, the laboratory cortisol assays, and the first industrial pilot to validate our predictive model of conscious emotional management.We are open to discussing the final roadmap and milestones with partners who bring both capital and strategic value to the mental health industry.

€150000. This pre-seed round is specifically designed to reach the next technical and commercial milestones: the full digital integration of Factor G and the execution of the first industrial validation pilot with biological biomarkers.

Data as a Service for the biomedical sector

We facilitate the search and acquisition of curated scientific and biomedical datasets.

Our platform enables R&D processes in health sciences, accelerating development with high-quality data. It also accelerates knowledge transfer from academia to industry by intermediating academic know-how for data curation. Finally, it impacts the recycling of valuable scientific information by aggregating and curating information that would otherwise remain siloed within organizations.

€160.000

€500.000

1. Design and development of podiatric insoles for prolonged use of high heels, aimed at improving the biomechanical health of the female foot. These insoles consist of a 2 mm polypropylene base, an internal longitudinal arch designed to control subtalar pronation, a latex cushion in the metatarsal area, and a technical lining that prevents sweat and odor. They will be developed in standard sizes and custom versions made from molds obtained using phenolic foam. 2. Standardized clinical protocols, based on scientific evidence, aimed at improving diagnostic and therapeutic efficiency in podiatry clinics and training centers. 3. Development of digital solutions: software or applications that enable biomechanical patient assessment, systematizing clinical analysis and facilitating data-driven therapeutic decision-making. 4. Development of innovative materials. Innovative methodologies such as digital simulators, augmented reality, and interactive 3D models are incorporated. 5. Technical and scientific consulting for academic institutions, clinics, and foot health innovation centers, with the aim of implementing continuous improvement systems, obtaining certifications for good clinical practices, and providing pedagogical guidance. 6. Publications, technical manuals, and innovative educational materials, resulting from professional experience and knowledge transfer, aimed at educational institutions, scientific publishers, and professionals in the field.

Correcting foot biomechanics with the use of high heels

Great impact on aesthetics and health

€80.000

0

IVAQ aims to revolutionize avalanche search and rescue operations with IVAQ Finder, a drone with the unique capability of locating autonomously Avalanche Beacons. With a compact design, a deployment time of less than one minute, and a web application accessible from any device, it provides rescue teams with a quick and effective response capability in situations where every second counts. A must-have in any avalanche scenario.

Search & Rescue in Avalanche scenarios

Avalanche victims die in 90% of cases of hypoxia. This means that avalanche rescue professionals take too long to unbury the victims. IVAQ Finder, with its unique capability of locating avalanche victims provides a tool for the teams to act faster while minimizing the risk taken by ground support teams. IVAQ Finder has the potential to save 100 lives per year. It can also help minimize the use of helicopters in these kind of missions and therefore minimize carbon emissions.

300k€

300k€

LiFT ENERGY, a spin-off of Politecnico di Milano, is advancing Li-Metal battery (LMB) technology through a patented process that significantly improves LMB electrochemical performance. The company’s core innovation lies in the development of a protective layer on lithium metal anodes, enabling LMBs to function as stable, rechargeable energy storage systems. This advancement addresses long-standing challenges associated with lithium metal anode degradation and represents a step forward in next-generation energy storage research.

The company’s core innovation lies in the development of a protective layer on lithium metal anodes, enabling Lithium Metal Batteries (LMBs) to function as stable, rechargeable energy storage systems.

LiFT Energy technology enable longer ranges for electric vehicles, lighter and more efficient batteries for drones, satellites, and airplanes, as well as significantly extended lifespan for consumer electronic devices.

500-1000 k€

Seed funding in 2026 = 2M€

VerdiX focuses on transforming complex agricultural bureaucracy into streamlined digital workflows, reducing time spent on paperwork and errors in compliance forms.​The platform also integrates tools to measure and monitor farm sustainability and carbon footprint, supporting more responsible and data-driven agriculture. At VerdiX, we keep the primary sector connected to the grants, subsidies, and opportunities that truly matter. Our team reviews the calls for proposals daily so you only receive information relevant to you and eligible to apply.

VerdiX solves the structural bureaucratic bottleneck in Spain's primary sector (agriculture, livestock, fishing), where farmers lose time, money, and aid eligibility due to complex, dispersed administrative processes. VerdiX technology is designed to solve the complexity and bureaucratic burden faced by primary sector farms (agriculture, livestock, and fishing) and specialized administrative agencies. It automates and digitizes complex administrative procedures such as grant applications, permits, and official declarations, reducing human error, saving time, and lowering operating costs. This allows businesses to focus on their core business instead of wasting resources on cumbersome administrative processes.

VerdiX technology will have a positive impact on society by simplifying the administrative management of businesses in the primary sector, such as farmers, ranchers, and fishermen. By automating complex procedures and reducing bureaucracy, it contributes to increased efficiency, reduced costs and errors, and allows professionals to focus on their core business. Furthermore, by digitizing processes, it promotes greater transparency, accessibility, and sustainability in business management, generating benefits for companies, the economy, and the community as a whole. VerdiX impacts society by reducing administrative burdens on over 900,000 Spanish farms, freeing farmers' time for production and boosting rural economic viability amid a sector contributing 2.3% to GDP.

€70.000

€250.000

AI4MUSEUMS is a University spin-off and cultural tech startup that develops a digital platform, named I-MUSE, designed to enhance the visibility, accessibility, and interconnectedness of museum collections. Building on advanced data analytics and AI-driven relational algorithms, I-MUSE allows museums to digitalize their artworks, manage content through an intuitive back-end, and create meaningful connections between collections across different institutions. Through a visitor-facing app, users can explore personalized cultural paths, discover lesser-known museums, and navigate thematic links between artworks using QR codes. For museums, especially small and medium-sized ones, I-MUSE offers an affordable, scalable SaaS solution to improve audience engagement, support data-driven decision-making, and strengthen territorial museum networks. The startup combines academic research, technological innovation, and cultural heritage valorization to promote more inclusive, sustainable, and connected cultural experiences.

I-MUSE addresses the problem of fragmentation and low visibility in the museum sector, especially for small and medium-sized institutions. Cultural collections are often presented in isolation, limiting cross-discovery and the ability to valorize territorial heritage as a whole. I-MUSE overcomes this by creating a connected, multi-museum digital network that links artworks, themes, and institutions, increasing visibility and fostering collaboration across museums. The platform also responds to the lack of accessible and scalable digital tools for museums. Many existing solutions are expensive or technically complex, making them unsuitable for smaller institutions. I-MUSE offers an affordable, SaaS-based solution with an intuitive back-end that allows museums to easily digitize, manage, and curate their content independently. Finally, I-MUSE tackles low and undifferentiated visitor engagement and the absence of data-driven decision-making. Through a visitor-facing app, personalized digital paths, and anonymized data collection, the platform enhances the visitor experience and enables museums to adopt more informed, evidence-based strategies for audience development and cultural programming.

I-MUSE contributes to society by making cultural heritage more accessible, connected, and inclusive. By digitally linking museums and collections, the platform helps citizens and visitors discover a wider range of cultural institutions, including small and lesser-known museums, fostering a more democratic access to culture and knowledge and enforcing a sense of cultural identity. The technology also supports sustainable cultural development at the territorial level. By strengthening cooperation among museums and promoting network-based cultural experiences, I-MUSE enhances local cultural ecosystems, supports sustainable tourism, and reinforces the social and economic value of cultural heritage for local communities, too often excluded by the most touristic activities. Finally, I-MUSE promotes digital innovation and data literacy in the cultural sector. By enabling museums to adopt data-driven tools and modern digital practices, the platform helps cultural institutions evolve toward more informed, adaptive, and resilient models of cultural management, with long-term benefits for education, participation, and cultural policy.

120.00€

No equity investment round has been raised to date, only academic POCs

We transform crayfish waste into chitosan, a high-value raw material used in cutting-edge industries.

It turns a polluting waste into a high-value, bio-based raw material, providing a sustainable alternative to fossil-based materials and enabling access to advanced materials used in cutting-edge industries.

Chitosan is such a versatile material that it can address challenges such as making bio-based materials to replace plastics, creating fire-retardant surfaces, and serving as hemostatic wound dressings.

€200.000

€200.000

The company develops FIBROKIT™, the first non-invasive urine test for the detection of renal fibrosis, with clinically validated accuracy comparable to biopsy. It enables earlier diagnosis of chronic kidney disease and improved patient follow-up, supporting more effective and personalised care.

Chronic kidney disease is diagnosed too late because current markers (creatinine, eGFR, albuminuria) only detect damage once kidney function is already impaired, not when renal injury first begins to develop. This delays intervention, worsens prognosis, and limits access to emerging therapies. Debios addresses this problem with FIBROKIT, a non-invasive test that detects renal fibrosis, the main prognostic factor of the disease, with biopsy-equivalent accuracy. Our patented urinary biomarker and proprietary monoclonal antibodies enable disease identification at very early stages, before kidney function is altered, allow risk stratification, monitoring of disease progression, and complement existing markers throughout the patient journey. In addition, we offer a scalable technology (ELISA and lateral flow) that is also suitable as a companion biomarker for the development of antifibrotic and cardiometabolic therapies, enabling earlier, more personalised, and more effective kidney care.

Debios develops non-invasive diagnostic tests for genitourinary diseases. FIBROKIT is its first test and enables the measurement of renal fibrosis from a urine sample, the main prognostic factor of chronic kidney disease, allowing early diagnosis and timely intervention to slow disease progression. SDG 3 – KDQOL-36 scale: −50% diagnostic uncertainty SDG 3 – KDQOL-36 scale: +25% personalised treatment SDG 10 – +25% early detection SDG 10 – 400 prescribers SDG 11 – −16,400 hospitalisation days SDG 12 – −€3.6M in waste and equipment use

€200.000

€1.700.000

Production of recombinant proteins through microorganisms, with a very short generation time, low cultivation cost and easily scalable with bioreactors in liquid medium.

Low-cost production of recombinant proteins. Reuse of industrial waste such as sewage sludge, brewery waste, whey, etc. to produce bio-fat.

Cheaper and more accessible recombinant proteins for the pharmaceutical, biotech, and medical industries. Reuse and recovery of industry by-products.

50.000 - 200.000 euros

50.000-200.000 euros

BIOLIZA is a Knowledge-Based Enterprise (KBE) from the University of Jaén, specializing in bioenergy, by-product valorization, and the circular economy. Since its founding in 2014, we have focused on the research and development of sustainable solutions to transform agricultural, forestry, and industrial waste into renewable energy, contributing to decarbonization and energy efficiency. At BIOLIZA, we thoroughly analyze the by-products generated by our clients to optimize their use. We evaluate the main energy valorization technologies, including: - Pyrolysis, for the production of biochar and biofuels. - Biomethane production, generating biogas as a renewable energy source. - Gasification, key to the production of green hydrogen and bioenergy. Our approach combines technical, energy, environmental, and economic analysis, guaranteeing viable and sustainable solutions for diverse industries.

BIOLIZA addresses several interconnected challenges related to waste management, energy sustainability, and climate change: - Inefficient management of agricultural, forestry, and industrial by-products, which are often underutilized or disposed of with negative environmental impacts. - High dependence on fossil fuels and limited integration of renewable energy sources in industrial and agro-food sectors. - Greenhouse gas emissions associated with waste treatment and conventional energy production. - Lack of technically and economically viable solutions tailored to the specific characteristics of biomass residues generated by each industry. Our technology-driven approach enables the conversion of organic by-products into renewable energy carriers (biogas, biomethane, biofuels, green hydrogen) and value-added products such as biochar. By combining technical, energy, environmental, and economic analysis, BIOLIZA delivers customized, scalable, and sustainable solutions that support decarbonization, circular economy implementation, and energy efficiency across diverse industries.

BIOLIZA’s technology delivers a positive and measurable impact on society by accelerating the transition towards a more sustainable, resilient, and low-carbon economy. - It reduces environmental pollution and greenhouse gas emissions by transforming agricultural, forestry, and industrial waste into renewable energy and valuable by-products. - It promotes energy security and energy independence, especially in rural and agro-industrial areas, by enabling local renewable energy generation. - It supports the circular economy, turning waste streams into resources and reducing the pressure on landfills and natural ecosystems. - It creates skilled employment and fosters knowledge transfer, strengthening innovation ecosystems linked to universities and research centers. - It enhances the competitiveness of industries and the agri-food sector by lowering energy costs and providing sustainable waste management solutions. Overall, BIOLIZA contributes to climate change mitigation, sustainable industrial development, and long-term societal well-being, in line with the UN Sustainable Development Goals.

N/A

N/A

LogMeal (AIGECKO Technologies S.L.) is a Barcelona-based AI startup that turns food images into structured, actionable data. Through our APIs and on-site “Kiosk” solution, we automatically recognize dishes and ingredients, estimate nutritional intake, and generate real-time insights for healthcare, sports performance, and food-service operations—supporting better nutrition monitoring, quality control, and measurable food-waste reduction.

Our technology solves four core problems where food data is traditionally manual, subjective, or missing: Lack of objective nutrition tracking at scale Hospitals, clinics, corporate canteens, and sports teams struggle to measure what people actually eat (not what was planned). We convert meal images into standardized nutrition data to support monitoring and interventions. Food waste is hard to measure and reduce Kitchens and operators often lack reliable, automated evidence of what was served vs. what was consumed. We generate consistent, auditable data that enables waste baselining, root-cause analysis, and continuous improvement. Manual quality control and compliance is expensive and inconsistent Food-service operations need proof for quality standards and public/private contract requirements, but data collection is labor-intensive. We provide real-time, structured evidence that supports QA workflows and reporting. Fragmented data across systems prevents decision-making Menus, production, POS, and nutrition systems are rarely connected end-to-end. We act as an interoperability layer: capturing data at the point of service and making it usable via API integrations for analytics, alerts, and reporting.

Our technology’s societal impact is primarily in public health, sustainability, and transparency in food systems: Better health outcomes through objective nutrition data By measuring real intake (not just planned menus or self-reports), healthcare providers and programs can improve nutrition monitoring and support prevention and management of chronic diseases (e.g., obesity, diabetes, cardiovascular conditions) with more precise interventions. Reduced food waste and environmental footprint Automated, consistent measurement enables kitchens and institutions to identify where waste occurs and act on it. Less waste means lower CO₂ impact, reduced resource consumption, and more efficient public spending in large-scale catering. Increased accountability and trust in institutional food services Schools, hospitals, and public canteens can provide auditable evidence of what was served and consumed, improving transparency for stakeholders and strengthening compliance with quality and procurement requirements. More efficient operations and better allocation of resources By replacing manual data collection with automated capture and analytics, institutions can redirect staff time to higher-value work, improve planning, and optimize budgets—especially relevant in public-sector settings.

€500.000

€500.000

Three Tensors was founded in 2024 by a group of three Computer Science and Systems Engineering professors to serve as a platform for industrial research and innovation. Its headquarters and main point of operations are in Bucharest, the capital of Romania, a technologically vibrant, innovative and active city. Our expertise is in Machine Learning (and especially numerical algorithms), Artificial Intelligence, Robotics, Control Theory, Telecommunications, Anomaly Detection, Cybersecurity, Fault Detection, and Isolation. We focus on accessing industrial research and development grants that build a sustainable and financially reliable innovation environment for our group with an emphasis on keeping young researchers, such as master and PhD students, engaged in our fields of expertise.

We provide secure localization services based on fusing multiple data sources to produce best outcomes.

Accuracte localization, will enable multiple better emergency response, person and transportation safety, logistic optimization, critical services continuity (with a potential impact on both public and military sectors).

€1M

€1M

Nsilica Simulation Technologies is a technology-driven startup and spin-off from the University of Vigo, founded in 2024 with a clear mission: to democratize lab-accuracy biomechanics. To achieve this, we developed nMotion, an AI-powered motion capture and biomechanical analysis system based on proprietary IMU hardware and software fully designed and developed in-house. nMotion combines wearable sensors with a cloud-based, user-friendly web application that allows professionals to easily capture, visualize, and analyze human movement. Our solution is designed for physiotherapy, rehabilitation, and sports performance, bringing laboratory-grade biomechanical insights to real-world environments. nMotion is currently being validated with early adopters across these sectors, while we progress through CE certification and prepare for our go-to-market phase.

Our technology addresses the lack of accessible, objective, and predictive tools In fields where technique and performance matter, better decisions depend on objective data. However, in rehabilitation and sports performance, access to high-quality biomechanical data is still limited. Current motion capture systems provide accurate measurements, but they are expensive, complex, and confined to specialized laboratories, making them inaccessible for everyday clinical or sports practice. As a result, many professionals still rely on subjective observation rather than quantitative movement analysis. nMotion addresses this gap by providing a user-friendly and accurate motion capture system designed specifically for professionals in physiotherapy, rehabilitation, and sports performance. Our solution enables the objective analysis of human movement, allowing practitioners to identify patterns, asymmetries, and trends over time, and to make better-informed decisions without the need for laboratory infrastructure. Here, we included a short video to show the technology: https://www.loom.com/share/0eb2b86aa7b34180b451682437a47850

Our technology contributes to society by making objective biomechanical analysis accessible beyond specialized laboratories, enabling professionals to base their decisions on quantitative data rather than subjective observation. In healthcare and rehabilitation, nMotion supports earlier detection of movement alterations, more personalized treatment planning, and continuous monitoring of patient progress. This is particularly relevant in the context of neurological and neurodegenerative diseases, where subtle changes in movement patterns over time can provide valuable information for assessing disease progression and treatment effectiveness. By enabling regular, objective movement assessment in real-world environments, nMotion can help clinicians track functional decline or improvement more precisely, supporting better-informed clinical decisions without adding complexity or burden to patients. More broadly, nMotion promotes a shift toward data-driven care in human movement, improving quality of life, reducing long-term healthcare costs, and democratizing access to biomechanical technologies that were previously limited to specialized centers.

We are raising €320,000 in this round, with €160,000 allocated to investors. This investment will enable us to finalize CE certification, complete product validation with early adopters, strengthen our hardware and software platform, and execute our initial go-to-market strategy. The round is structured to take nMotion from late validation to early commercialization.

€320,000